BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohort Study.
Galia ZacayDavid ShashaRonen BareketItai KadimFabienne Hershkowitz SikronJudith TsamirDavid MossinsonAnthony D HeymannPublished in: Open forum infectious diseases (2021)
In this study, vaccination with BNT162b2 reduced infection rates among individuals who underwent screening by frequent SARS-CoV-2 PCR testing. Using a cohort of frequently tested individuals reduced the indication bias for the PCR testing, which enabled estimation of infection rates.